{
    "title": "103_hr3100",
    "content": "The \"National Drug Policy Act of 1993\" establishes the \"Commission on National Drug Policy\" with specific duties. The Commission on National Drug Policy will conduct a study on the unlawful production, distribution, and use of controlled substances in the United States. This includes investigating the causes of unlawful substance use, evaluating existing Federal laws, and analyzing the costs and benefits of current national drug policy. The Commission on National Drug Policy will analyze the allocation of funds for combating unlawful controlled substances, including interdiction, law enforcement, prevention, and rehabilitation methods. Within 18 months, a report on these aspects will be submitted. The Commission on National Drug Policy will submit a comprehensive report to the President, Speaker of the House, and President pro tempore of the Senate, including conclusions, recommendations, and proposals for legislation and administrative action based on their study. The report will be made available to the public upon request. The Commission on National Drug Policy will submit a report with conclusions, recommendations, and legislative proposals to the President, Speaker of the House, and President pro tempore of the Senate. The Commission on National Drug Policy will consist of 13 members appointed by the President, Senate leaders, and House leaders within 60 days of the Act's enactment. The Commission on National Drug Policy will consist of 13 members appointed by various authorities within 60 days of the Act's enactment. Individuals from professions dealing with controlled substances are qualified for appointment, while elected Federal officials are not eligible. Appointing authorities should consider individuals such as law enforcement officials, physicians, social workers, judges, DEA staff, drug rehabilitation counselors, religious leaders, community leaders, educators, and academics with expertise in drug-related issues. The Commission on National Drug Policy consists of 13 members appointed for life, with vacancies filled promptly. Members are paid based on GS-15 rates for their duties. The Commission on National Drug Policy consists of 13 members appointed for life, with vacancies filled promptly. Members may not receive additional compensation as federal employees, but are allowed travel expenses while performing Commission duties. Seven members constitute a quorum for hearings. The Commission on National Drug Policy consists of 13 members appointed for life, with vacancies filled promptly. Members may not receive additional compensation as federal employees, but are allowed travel expenses while performing Commission duties. Seven members constitute a quorum for hearings. The President designates a chairperson and vice chairperson for the Commission, who must meet at least once a month. The Commission on National Drug Policy consists of 13 members appointed for life, with vacancies filled promptly. Members may not receive additional compensation as federal employees, but are allowed travel expenses while performing Commission duties. Seven members constitute a quorum for hearings. The President designates a chairperson and vice chairperson for the Commission, who must meet at least once a month. SEC. 5. STAFF OF COMMISSION; EXPERTS AND CONSULTANTS. The Commission may appoint staff and fix their pay as appropriate, without following certain civil service laws. Staff pay cannot exceed the maximum rate for grade GS-15. The Commission can also procure temporary services from experts and consultants. The Commission can appoint staff and set their pay without following certain civil service laws. Staff pay should not exceed the maximum rate for grade GS-15. Federal agencies can also detail personnel to the Commission on a reimbursable basis. The Commission has the power to appoint staff, set their pay, and detail personnel from federal agencies on a reimbursable basis. The Commission has the authority to hold hearings, conduct sessions, and take testimony as needed. Meetings must be open to the public, and transcripts of hearings will be published and made available upon request. Members and agents of the Commission can take actions authorized by the Commission. The Commission is authorized to obtain official information from Federal agencies as needed to carry out its duties. The Commission must adhere to restrictions on the use and disclosure of this information. Additionally, the Commission is permitted to use the United States mails for official purposes. The Commission is authorized to use the United States mails and obtain administrative support services for carrying out its duties. It can also make expenditures and enter into contracts as needed, within the limits set by appropriations Acts. The Commission will terminate 60 days after submitting the required report. SEC. 8. DEFINITIONS. The Commission refers to the Commission on National Drug Policy, controlled substance is defined by the Controlled Substances Act, distribute means distribution as defined by the Act, Federal agency is an executive agency, and production is defined by the Controlled Substances Act."
}